Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

78%

7 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

7(77.8%)

N/A

2(22.2%)

9Total

Phase 3(7)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07395141Phase 3Not Yet Recruiting

Albumin in Acute Variceal Bleeding

Role: lead

NCT06737822Phase 3Recruiting

Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:

Role: collaborator

NCT06377397Phase 3Not Yet Recruiting

Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates

Role: collaborator

NCT03280147Phase 3Completed

7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis

Role: collaborator

NCT04910750Not ApplicableCompleted

Tools for the Integrated Management of Childhood Illness (TIMCI): Evaluation of Pulse Oximetry & Clinical Decision Support Algorithms in Primary Care

Role: collaborator

NCT00832143Not ApplicableCompleted

Effect of Referral Card on Neonatal Medical Care Seeking for Institutional Births in Urban Lucknow

Role: lead

NCT00396526Phase 3Completed

ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia

Role: lead

NCT00407394Phase 3Completed

Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze

Role: lead

NCT00396500Phase 3Completed

Deworming and Vitamin A (DEVTA) Prepilot Study

Role: lead

All 9 trials loaded